E. OKULU Et Al. , "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion," Frontiers in Pediatrics , vol.10, 2022
OKULU, E. Et Al. 2022. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion. Frontiers in Pediatrics , vol.10 .
OKULU, E., ERDEVE, Ö., Kilic, I., Olukman, O., Calkavur, S., Buyukkale, G., ... Cetinkaya, M.(2022). Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion. Frontiers in Pediatrics , vol.10.
OKULU, EMEL Et Al. "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion," Frontiers in Pediatrics , vol.10, 2022
OKULU, EMEL Et Al. "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion." Frontiers in Pediatrics , vol.10, 2022
OKULU, E. Et Al. (2022) . "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion." Frontiers in Pediatrics , vol.10.
@article{article, author={EMEL OKULU Et Al. }, title={Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion}, journal={Frontiers in Pediatrics}, year=2022}